Imatge de la portada

Introduction to Basics of Pharmacology and Toxicology Volume 4: Pharmacology and Therapeutics /

This Book is the 4th and final volume of the series under the title, “Introduction to Basics of Pharmacology and Toxicology” – with a primary focus on clinical pharmacology and therapeutics aspects. The initial and major part of this volume provides an extensive description of the use of drugs in cl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor corporatiu: SpringerLink (Online service)
Altres autors: Arivazhahan, Avinash (Editor), Shah, Neel (Editor), Sandhiya, Selvarajan (Editor), Raj, Gerard Marshall (Editor)
Format: Electrònic eBook
Idioma:anglès
Publicat: Singapore : Springer Nature Singapore : Imprint: Springer, 2025.
Edició:1st ed. 2025.
Matèries:
Medicine > Research.
Biology > Research.
Ethics.
Pharmacy.
Pharmacovigilance.
Biomedical Research.
Moral Philosophy and Applied Ethics.
Drug Safety and Pharmacovigilance.
Accés en línia:https://doi.org/10.1007/978-981-95-1920-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Taula de continguts:
  • 1. Clinical Pharmacokinetics
  • 2. Essential medicines and rational use of drugs
  • 3. Drug Information Centre
  • 4. Evidence-Based Medicine
  • 5. Medication Adherence
  • 6. Therapeutic Drug Monitoring
  • 7. Medication Error
  • 8. Drug use in pregnancy and lactation (Perinatal pharmacology)
  • 9. Pediatric Pharmacology
  • 10. Geriatric Pharmacology
  • 11. Usage of drugs in various Pathological States
  • 12. High throughput screening and computer-aided drug designing
  • 13. Phase 0 Clinical Trials
  • 14. Phase 1 Clinical Trials
  • 15. Phase 2 Clinical Trials
  • 16. Phase 3 Clinical Trials
  • 17. Phase 4 Clinical trials
  • 18. Ethics in Clinical Trials
  • 19. Vaccine Clinical Trials
  • 20. Real-World Evidence Studies and Pragmatic Clinical Trials
  • 21. Contract Research Organizations - Roles & Responsibilities
  • 22. Bioavailability and Bioequivalence Studies
  • 23. New Drugs and Clinical trial rules 2019
  • 24. Regulation of healthcare products by the United States Food and Drug Administration and Health Canada
  • 25. Regulation of healthcare products by the United States Food and Drug Administration and Health Canada
  • 26. Medical Device and Medical Device Regulations
  • 27. Off-Label Use of Drugs
  • 28. Nonclinical testing methods to assess safety and efficacy of new drugs
  • 29. Novel Chemical and Biological Entities in the Past Five Years
  • 30. Drug Repurposing
  • 31. Specialized Drug Delivery System
  • 32. Biologicals and Biosimilars.

Ítems similars